Related content

Editorial Comment from Dr Yoshimura to Demographics, management and treatment outcomes of benign and malignant retroperitoneal tumors in Japan

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : 68-69

John Wiley & Sons Inc

Access to resources Recommend Favorite

Demographics, management and treatment outcomes of benign and malignant retroperitoneal tumors in Japan

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : 61-67

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial Comment from Dr Izumi to Clinical outcomes of prostate cancer patients in Yokosuka City, Japan: A comparative study between cases detected by prostate‐specific antigen‐based screening in Yokosuka and those detected by other means

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 8, 2015-08 ,pp. : 752-753

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial Comment from Dr Stamatiou to Clinical outcomes of prostate cancer patients in Yokosuka City, Japan: A comparative study between cases detected by prostate‐specific antigen‐based screening in Yokosuka and those detected by other means

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 8, 2015-08 ,pp. : 753-753

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial Comment from Dr Oh‐oka to Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Secondary results from a 6‐month, randomized, double‐blind study comparing finasteride plus tadalafil with finasteride plus placebo

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 6, 2015-06 ,pp. : 588-588

John Wiley & Sons Inc

Access to resources Recommend Favorite